{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:08:16Z","timestamp":1791065296023,"version":"4.1.0"},"reference-count":81,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2015.00011","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T14:43:06Z","timestamp":1423579386000},"source":"Crossref","is-referenced-by-count":35,"title":["A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties"],"prefix":"10.3389","volume":"6","author":[{"given":"Hee-Kyoung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misty D.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Walewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem A.","family":"Vellore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Steve","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldomero M.","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Bulaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1158\/1078-0432.CCR-10-0659","article-title":"Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.","volume":"16","author":"Alifano","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1213\/01.ANE.0000219586.65112.FA","article-title":"An assessment of the antinociceptive efficacy of intrathecal and epidural Contulakin-G in rats and dogs.","volume":"104","author":"Allen","year":"2007","journal-title":"Anesth. Analg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0006-8993(91)90139-M","article-title":"Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem.","volume":"557","author":"al-Rodhan","year":"1991","journal-title":"Brain Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0014-5793(86)80565-8","article-title":"Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29.","volume":"201","author":"Amar","year":"1986","journal-title":"FEBS Lett."},{"issue":"3684","key":"B5","doi-asserted-by":"publisher","DOI":"10.10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath.","volume":"81","author":"Berensen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"B6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/bs4020125","article-title":"Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders.","volume":"4","author":"Boules","year":"2014","journal-title":"Behav. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.peptides.2005.12.018","article-title":"Bioactive analogs of neurotensin: focus on CNS effects.","volume":"27","author":"Boules","year":"2006","journal-title":"Peptides"},{"issue":"36","key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00036","article-title":"Diverse roles of neurotensin agonists in the central nervous system.","volume":"4","author":"Boules","year":"2013","journal-title":"Front. Endocrinol."},{"key":"B9","author":"Case","year":"2012","journal-title":"AMBER12."},{"key":"B10","author":"Case","year":"2012","journal-title":"AmberTools 12."},{"key":"B11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1034\/j.1399-3011.2000.00154.x","article-title":"Chemical synthesis and receptor binding of catfish somatostatin: a disulfide-bridged beta-D-Galp-(1\u00e2\u20ac\u201c > 3)-alpha-D-GalpNAc O-glycopeptide.","volume":"55","author":"Chen","year":"2000","journal-title":"J. Pept. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0165-6147(99)01351-6","article-title":"Partial agonists and G protein-coupled receptor desensitization.","volume":"20","author":"Clark","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"98","key":"B13","volume":"6","author":"Craig","year":"2002","journal-title":"Contulakin-G, Analogs thereof and Uses thereof,"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13752","DOI":"10.1074\/jbc.274.20.13752","article-title":"Contulakin-G, an O-glycosylated inverterate neurotensin.","volume":"274","author":"Craig","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/pr.110.003244","article-title":"Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.","volume":"63","author":"Cunningham","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N(dot)log(N) method for Ewald sums in large systems.","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1172\/JCI70647","article-title":"Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.","volume":"124","author":"Demeule","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/cells2010124","article-title":"The anti-apoptotic role of neurotensin.","volume":"2","author":"Devader","year":"2013","journal-title":"Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1016\/j.bmcl.2014.06.033","article-title":"The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).","volume":"24","author":"Di Fruscia","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1007\/s00018-005-5128-x","article-title":"Multitasking with neurotensin in the central nervous system.","volume":"62","author":"Dobner","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.peptides.2006.04.025","article-title":"Neurotensin and pain modulation.","volume":"27","author":"Dobner","year":"2006","journal-title":"Peptides"},{"issue":"e4223","key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004223","article-title":"The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression.","volume":"4","author":"Dupouy","year":"2009","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1476-5381.2009.00262.x","article-title":"Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.","volume":"158","author":"Duringer","year":"2009","journal-title":"Br. J. Pharm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E655","DOI":"10.1073\/pnas.1317903111","article-title":"Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli.","volume":"111","author":"Egloff","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1021\/jm200006c","article-title":"Discovery of highly potent and neurotensin receptor 2 selective neurotensin mimetics.","volume":"54","author":"Einsiedel","year":"2011","journal-title":"J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/psc.2493","article-title":"Nanoparticles exposing neurotensin tumor-specific drivers.","volume":"19","author":"Falciani","year":"2013a","journal-title":"J. Pept. Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1021\/jm400329p","article-title":"Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors.","volume":"56","author":"Falciani","year":"2013b","journal-title":"J. Med. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/cmdc.200900527","article-title":"Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.","volume":"5","author":"Falciani","year":"2010","journal-title":"ChemMedChem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0008-6215(96)00324-2","article-title":"Chemoenzymatic synthesis of the Thomsen-Friedenreich antigen determinant.","volume":"299","author":"Gambert","year":"1997","journal-title":"Carbohyd. Res."},{"key":"B30","first-page":"4851","article-title":"The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.","volume":"61","author":"Glinsky","year":"2001","journal-title":"Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1399-3011.1992.tb00104.x","article-title":"Synthesis and biological activity of the mono- and di-galactosyl-vespulakinin 1 analogues.","volume":"40","author":"Gobbo","year":"1992","journal-title":"Int. J. Pept. Protein Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1021\/ct200909j","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born.","volume":"8","author":"Gotz","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"B33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/psc.1266","article-title":"Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities.","volume":"16","author":"Green","year":"2010","journal-title":"J. Pept. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/mol.106.028258","article-title":"An opioid agonist that does not induce mu-opioid receptor-arrestin interactions or receptor internalization.","volume":"71","author":"Groer","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuroscience.2004.04.034","article-title":"Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats.","volume":"126","author":"Gui","year":"2004","journal-title":"Neuroscience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.2174\/138161208785777469","article-title":"Conus venoms \u00e2\u20ac\u201c a rich source of peptide-based therapeutics.","volume":"14","author":"Han","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.113.205310","article-title":"Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.","volume":"346","author":"Hanson","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cmdc.201200376","article-title":"Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand.","volume":"8","author":"Held","year":"2013","journal-title":"ChemMedChem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bmcl.2013.11.026","article-title":"Imidazole-derived agonists for the neurotensin 1 receptor.","volume":"24","author":"Hershberger","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water.","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"B41","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.1021\/jp8001614","article-title":"Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations.","volume":"112","author":"Joung","year":"2008","journal-title":"J. Phys. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1037\/a0037912","article-title":"Systemic administration of the neurotensin nts1-receptor agonist pd149163 improves performance on a memory task in naturally deficient male brown norway rats.","volume":"22","author":"Keiser","year":"2014","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1213\/01.ane.0000262038.58546.e6","article-title":"The pharmacokinetics of the conopeptide Contulakin-G (CGX-1160) after intrathecal administration: an analysis of data from studies in beagles.","volume":"104","author":"Kern","year":"2007","journal-title":"Anesth. Anal."},{"key":"B44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2013.03.004","article-title":"Neurotensin and neurotensin receptors: characteristic, structure-activity relationship, and pain modulation-a review.","volume":"716","author":"Kleczkowska","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/psc.477","article-title":"Synthetic glycopeptides for the development of tumour-selective vaccines.","volume":"9","author":"Kunz","year":"2003","journal-title":"J. Pept. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cmdc.200800421","article-title":"Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy.","volume":"4","author":"Lee","year":"2009","journal-title":"ChemMedChem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding.","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov. Des."},{"issue":"143","key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00143","article-title":"Neurotensin and its receptors in the control of glucose homeostasis.","volume":"3","author":"Mazella","year":"2012","journal-title":"Front. Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.peptides.2006.02.012","article-title":"Internalization and recycling properties of neurotensin receptors.","volume":"27","author":"Mazella","year":"2006","journal-title":"Peptides"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"Chem. Theory Comput."},{"key":"B51","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models.","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J. Comput. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcc.21276","article-title":"Protein\u00e2\u20ac\u201cprotein docking dealing with the unknown.","volume":"31","author":"Moreira","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1749-6632.1992.tb27346.x","article-title":"Neurotensin, antipsychotic drugs, and schizophrenia.","volume":"668","author":"Nemeroff","year":"1992","journal-title":"Basic Clin. Stud. Ann. N. Y. Acad. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1091\/mbc.8.11.2101","article-title":"E. E. Just Lecture, 1996. Conus venom peptides, receptor and ion channel targets, and drug design: 50 million years of neuropharmacology.","volume":"8","author":"Olivera","year":"1997","journal-title":"Mol. Biol. Cell"},{"key":"B55","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0959-4388(99)00033-1","article-title":"Effects of Conus peptides on the behavior of mice.","volume":"9","author":"Olivera","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1080\/00268978800101881","article-title":"An analysis of the accuracy of Langevin and molecular dynamics algorithms.","volume":"65","author":"Pastor","year":"1988","journal-title":"Mol. Phys."},{"key":"B57","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1021\/ml400176n","article-title":"Discovery of ML314, a brain penetrant non-peptidic beta-arrestin biased agonist of the neurotensin NTR1 receptor.","volume":"4","author":"Peddibhotla","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.peptides.2006.04.027","article-title":"Interactions between neurotensin receptors and G proteins.","volume":"27","author":"Pelaprat","year":"2006","journal-title":"Peptides"},{"key":"B59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0742-8413(93)90193-O","article-title":"Presynaptic block of transmission in the insect cns by mono- and di-galactosyl analogues of vespulakinin 1, a wasp (Paravespula maculifrons) venom neurotoxin.","volume":"105","author":"Piek","year":"1993","journal-title":"Comput. Biochem. Physiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1399-3011.1987.tb03332.x","article-title":"Synthesis, conformation, and biological activity of the carbohydrate-free vespulakinin 1.","volume":"30","author":"Rocchi","year":"1987","journal-title":"Int. J. Pept. Protein Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1471-4159.2007.05205.x","article-title":"Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model.","volume":"105","author":"Roussy","year":"2008","journal-title":"J. Neurochem."},{"key":"B62","author":"Schr\u00c3\u00b6dinger","year":"2012","journal-title":"Schr\u00c3\u00b6dinger Suite 2012."},{"key":"B63","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1021\/bi02891x","article-title":"Analysis of protein-carbohydrate interaction at the lower size limit of the protein part (15-mer peptide) by NMR spectroscopy, electrospray ionization mass spectrometry, and molecular modeling.","volume":"41","author":"Siebert","year":"2002","journal-title":"Biochemistry"},{"key":"B64","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2826.2001.00658.x","article-title":"Maintaining cell sensitivity to G-protein coupled receptor agonists: neurotensin and the role of receptor gene activation.","volume":"13","author":"Souaze","year":"2001","journal-title":"J. Neuroendocrinol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1158\/0008-5472.CAN-06-0450","article-title":"Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.","volume":"66","author":"Souaze","year":"2006","journal-title":"Cancer Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.peptides.2006.04.029","article-title":"Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.","volume":"27","author":"Souaze","year":"2006","journal-title":"Peptides"},{"key":"B67","doi-asserted-by":"publisher","first-page":"10087","DOI":"10.1074\/jbc.272.15.10087","article-title":"Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms.","volume":"272","author":"Souaze","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"e103520","key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103520","article-title":"Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.","volume":"9","author":"Tirupula","year":"2014","journal-title":"PLoS ONE"},{"key":"B69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0022-3565(25)13201-1","article-title":"Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells.","volume":"253","author":"Turner","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1002\/pro.5560050621","article-title":"Tumor marker disaccharide D-Gal-beta 1, 3-GalNAc complexed to heat-labile enterotoxin from Escherichia coli.","volume":"5","author":"van den Akker","year":"1996","journal-title":"Protein Sci."},{"key":"B71","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1242\/jcs.113.17.2963","article-title":"Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor.","volume":"113(Pt 17)","author":"Vandenbulcke","year":"2000","journal-title":"J. Cell Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0165-6147(99)01357-7","article-title":"Neurotensin and neurotensin receptors.","volume":"20","author":"Vincent","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"B73","article-title":"\u00e2\u20ac\u0153Glycosylation is critical for the pharmacologic properties of contulakin, a potent, broad-spectrum analgesic conopeptide,\u00e2\u20ac\u009d in","author":"Wagstaff","year":"2000","journal-title":"Proceedings of the 30th Annual Meeting, Society for Neuroscience,"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.carres.2005.11.010","article-title":"Chemical synthesis of analogs of the glycopeptide contulakin-G, an analgetically active conopeptide from Conus geographus.","volume":"341","author":"Westerlind","year":"2006","journal-title":"Carbohydr. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature11558","article-title":"Structure of the agonist-bound neurotensin receptor.","volume":"490","author":"White","year":"2012","journal-title":"Nature"},{"issue":"184","key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2012.00184","article-title":"Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.","volume":"3","author":"Wu","year":"2013","journal-title":"Front. Endocrinol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0960-894X(95)00155-M","article-title":"Reduced amide bond neurotensin 8\u00e2\u20ac\u201c13 mimetics with potent in vivo activity.","volume":"5","author":"Wustrow","year":"1995","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1021\/bi00646a010","article-title":"Vespulakinins: new carbohydrate-containing bradykinin derivatives.","volume":"15","author":"Yoshida","year":"1976","journal-title":"Biochemistry"},{"key":"B79","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.18632\/oncotarget.1633","article-title":"Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine\/paracrine activation in lung tumors, confirming responsiveness to erlotinib.","volume":"5","author":"Younes","year":"2014","journal-title":"Oncotarget"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1021\/jm801481y","article-title":"Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin.","volume":"52","author":"Zhang","year":"2009","journal-title":"J. Med. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-013-1920-3","article-title":"Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.","volume":"389","author":"Zhang","year":"2014","journal-title":"Mol. Cell Biochem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T20:04:44Z","timestamp":1747598684000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2015.00011\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":81,"URL":"https:\/\/doi.org\/10.3389\/fphar.2015.00011","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]}}}